Patent intelligence · US
US 11311503
Sterile aqueous choline salt compositions
Sterile aqueous choline salt compositions
Patent details — US 11311503
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 26, 2022
- Expiration
- Apr 21, 2042
- Applicant
- PROTARA THERAPEUTICS, INC.
- Claims
- 20
- CPC classes
- A61K, A61K31/14, A61K9/0019
Quick answer
US 11311503 (Sterile aqueous choline salt compositions) is held by PROTARA THERAPEUTICS, INC.. Status: granted. Granted Apr 26, 2022. Expires Apr 21, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- PROTARA THERAPEUTICS, INC.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K31/14, A61K9/0019
More from PROTARA THERAPEUTICS, INC.
Related pharmaceutical patents in our USPTO index.
Related coverage
Frequently asked questions
What is US patent 11311503?
US 11311503 (Sterile aqueous choline salt compositions) is held by PROTARA THERAPEUTICS, INC.. Status: granted. Granted Apr 26, 2022. Expires Apr 21, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11311503?
PROTARA THERAPEUTICS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 11311503 expire?
Our index shows an expiration date of Apr 21, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.